Firmenbeschreibung
Biogen Idec Inc. ist ein US-Biotech-Unternehmen, das sich auf die Entwicklung lebensrettender, lebensverlängernder und die Lebensqualität verbessernder Medikamente spezialisiert hat. Der Konzern forscht im neurologischen Bereich und beschäftigt sich insbesondere mit der multiplen Sklerose, sowie - in Deutschland - mit der Schuppenflechte. Darüber hinaus arbeitet das Unternehmen in den Bereichen Onkologie, Rheumatologie und Hämophilie. Zu den ersten großen Erfolgen zählt ein erstmalig gentechnisch hergestellter Impfstoff gegen Hepatitis B. Außerdem produzierte das Unternehmen verschiedene Medikamente die bei Krebs, Hepatitis und Multipler Sklerose eingesetzt werden.
KeyData
| endOfFinancialYear: | 31.12.2024 00:00 |
| stockholderStructure: | PRIMECAP MANAGEMENT CO CA (11.1709%),Vanguard Group (9.89536%),BlackRock Inc. (9.785%),State Street Corporation (4.77048%),"T. Rowe Price Investment Management, Inc." (3.67956%),Wellington Management Group (3.65694%),JP Morgan Chase & Co. (3.44191%),GEODE CAPITAL MANAGEMENT LLC (2.27293%),Invesco Ltd. (1.24636%),Clearbridge Investments LLC (1.15339%) |
| sharesOutstanding: | 145719340.0000 |
| ceo: | Christopher A. Viehbacher |
| board: | Michael McDonnell, Dr. Ginger Gregory, Rachid Izzar, Susan H. Alexander, Nicole Murphy, Priya Singhal |
| supervisoryBoard: | Caroline Dorsa, Eric K. Rowinsky, Jesus B. Mantas, Maria C. Freire, Stephen A. Sherwin, William A. Hawkins, Susan Langer, Christopher A. Viehbacher, Lloyd B. Minor |
| countryID: | 20 |
| freeFloat: | 72.2000 |
| faceValue: | 0.0005 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Biotechnologie |
| industryName: | Biotechnologie |
| subsectorName: | Biotechnologie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Karen Jewell |
| phone: | 781-464-2442 |
| email: | IR@biogenidec.com |
| irWebSite: | https://investors.biogen.com/ |
Adresse
| street: | 225 Binney Street |
| city: | Cambridge, Massachusetts 02142, USA |
| phone: | +1 781-464-2000 |
| fax: | +1-617-679-2617 |
| webSite: | www.biogen.com |
Finanzen (kurz)
| year: | 2021 | cash: | 2261.4000 |
| balanceSheetTotal: | 23877.3000 | liabilities: | 12917.6000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 10959.7000 |
| sales: | 10981.7000 | bankLoans: | 3722.0000 |
| incomeBeforeTaxes: | 1745.2000 | netIncome: | 1556.1000 |
| cashFlow: | 990.0000 | employees: | 9610 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2022 | cash: | 3419.3000 |
| balanceSheetTotal: | 24554.1000 | liabilities: | 11165.7000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 13388.4000 |
| sales: | 10173.4000 | incomeBeforeTaxes: | 3591.8000 |
| netIncome: | 3046.9000 | cashFlow: | 1213.6000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 1049.9000 |
| balanceSheetTotal: | 26844.8000 | liabilities: | 12045.4000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 14799.4000 |
| sales: | 9835.6000 | incomeBeforeTaxes: | 1296.8000 |
| netIncome: | 1161.1000 | cashFlow: | -2404.5000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 2261.4000 |
| balanceSheetTotal: | 23877.3000 |
| liabilities: | 12917.6000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 10959.7000 |
| sales: | 10981.7000 |
| bankLoans: | 3722.0000 |
| incomeBeforeTaxes: | 1745.2000 |
| netIncome: | 1556.1000 |
| cashFlow: | 990.0000 |
| employees: | 9610 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 3419.3000 |
| balanceSheetTotal: | 24554.1000 |
| liabilities: | 11165.7000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 13388.4000 |
| sales: | 10173.4000 |
| incomeBeforeTaxes: | 3591.8000 |
| netIncome: | 3046.9000 |
| cashFlow: | 1213.6000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 1049.9000 |
| balanceSheetTotal: | 26844.8000 |
| liabilities: | 12045.4000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 14799.4000 |
| sales: | 9835.6000 |
| incomeBeforeTaxes: | 1296.8000 |
| netIncome: | 1161.1000 |
| cashFlow: | -2404.5000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 24554.1000 | cash: | 3419.3000 |
| currentAssets: | 9791.2000 | fixedAssets: | 14762.9000 |
| liabilities: | 3272.8000 | totalLiabilitiesEquity: | 24554.1000 |
| totalShareholdersEquity: | 13388.4000 | property: | 3298.6000 |
| intangibleAssets: | 1850.1000 | longTermInvestments: | 705.7000 |
| inventories: | 1344.4000 | accountsReceivable: | 1705.0000 |
| accountsPayable: | 491.5000 | liabilitiesTotal: | 11165.7000 |
| longTermDebt: | 6281.0000 | shortTermDebt: | 0.0000 |
| minorityInterests: | -9.5000 | commonStock: | 0.1000 |
| preferredStock: | 0.0000 | sales: | 10173.4000 |
| depreciation: | 518.4000 | netIncome: | 3046.9000 |
| incomeInterest: | -157.3000 | investments: | 2231.1000 |
| incomeTaxes: | 632.8000 | costGoodsSold: | 2278.3000 |
| grossProfit: | 7895.1000 | minorityInterestsProfit: | -85.3000 |
| cashFlow: | 1384.3000 | cashFlowInvesting: | 1576.6000 |
| cashFlowFinancing: | -1747.3000 | cashFlowTotal: | 1213.6000 |
| accountingStandard: | US GAAP | equityRatio: | 54.5261 |
| debtEquityRatio: | 0.4691 | liquidityI: | 1.0448 |
| liquidityII: | 1.5657 | netMargin: | 29.9497 |
| grossMargin: | 77.6053 | cashFlowMargin: | 13.6071 |
| ebitMargin: | 0.0000 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 26.8277 | preTaxROA: | 14.6281 |
| roe: | 22.7578 | roa: | 12.4089 |
| netIncomeGrowth: | 95.8036 | revenuesGrowth: | -7.3604 |
| taxExpenseRate: | 17.6179 | equityTurnover: | 0.7599 |
| epsBasic: | 20.9600 | epsDiluted: | 20.8700 |
| epsBasicGrowth: | 100.7663 | shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 3591.8000 | priceEarningsRatioCompany: | 13.2118 |
| priceCashFlowRatio: | 28.9034 | bookValuePerShare: | 92.6625 |
| marketCap: | 40010965090.3200 | earningsYield: | 7.5690 |
| pegRatio: | 0.1311 | cashFlowPerShare: | 9.5809 |
| netAssetsPerShare: | 92.5967 | priceBookValueRatio: | 2.9885 |
| priceEarningsRatio: | 13.1317 | netEarningsPerShare: | 21.0879 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 26844.8000 | cash: | 1049.9000 |
| currentAssets: | 6859.3000 | fixedAssets: | 19985.5000 |
| liabilities: | 3434.3000 | totalLiabilitiesEquity: | 26844.8000 |
| totalShareholdersEquity: | 14799.4000 | property: | 3309.7000 |
| intangibleAssets: | 8363.0000 | longTermInvestments: | 0.0000 |
| inventories: | 2527.4000 | accountsReceivable: | 1664.1000 |
| accountsPayable: | 403.3000 | liabilitiesTotal: | 12045.4000 |
| longTermDebt: | 6788.2000 | shortTermDebt: | 150.0000 |
| minorityInterests: | 0.0000 | commonStock: | 0.1000 |
| preferredStock: | 0.0000 | sales: | 9835.6000 |
| depreciation: | 494.8000 | netIncome: | 1161.1000 |
| incomeInterest: | -29.6000 | investments: | 2462.0000 |
| incomeTaxes: | 135.3000 | costGoodsSold: | 2533.4000 |
| grossProfit: | 7302.2000 | minorityInterestsProfit: | 0.4000 |
| cashFlow: | 1547.2000 | cashFlowInvesting: | -4101.0000 |
| cashFlowFinancing: | 149.3000 | cashFlowTotal: | -2404.5000 |
| accountingStandard: | US GAAP | equityRatio: | 55.1295 |
| debtEquityRatio: | 0.4688 | liquidityI: | 0.3057 |
| liquidityII: | 0.7903 | netMargin: | 11.8051 |
| grossMargin: | 74.2425 | cashFlowMargin: | 15.7306 |
| ebitMargin: | 0.0000 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 8.7625 | preTaxROA: | 4.8307 |
| roe: | 7.8456 | roa: | 4.3252 |
| netIncomeGrowth: | -61.8924 | revenuesGrowth: | -3.3204 |
| taxExpenseRate: | 10.4334 | equityTurnover: | 0.6646 |
| epsBasic: | 8.0200 | epsDiluted: | 7.9700 |
| epsBasicGrowth: | -61.7366 | shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 1296.8000 | priceEarningsRatioCompany: | 32.2656 |
| priceCashFlowRatio: | 24.3117 | bookValuePerShare: | 101.8115 |
| marketCap: | 37615013698.4600 | earningsYield: | 3.0993 |
| pegRatio: | -0.5226 | cashFlowPerShare: | 10.6439 |
| netAssetsPerShare: | 101.8115 | priceBookValueRatio: | 2.5417 |
| priceEarningsRatio: | 32.3960 | netEarningsPerShare: | 7.9877 |
| currency: | USD |
| year: | 2024 | priceEarningsRatioCompany: | 20.0287 |
| priceCashFlowRatio: | 15.0913 | bookValuePerShare: | 101.8115 |
| marketCap: | 23406897584.2000 | earningsYield: | 4.9928 |
| pegRatio: | -0.3244 | cashFlowPerShare: | 10.6439 |
| netAssetsPerShare: | 101.8115 | priceBookValueRatio: | 1.5777 |
| priceEarningsRatio: | 20.1096 | netEarningsPerShare: | 7.9877 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 24554.1000 |
| cash: | 3419.3000 |
| currentAssets: | 9791.2000 |
| fixedAssets: | 14762.9000 |
| liabilities: | 3272.8000 |
| totalLiabilitiesEquity: | 24554.1000 |
| totalShareholdersEquity: | 13388.4000 |
| property: | 3298.6000 |
| intangibleAssets: | 1850.1000 |
| longTermInvestments: | 705.7000 |
| inventories: | 1344.4000 |
| accountsReceivable: | 1705.0000 |
| accountsPayable: | 491.5000 |
| liabilitiesTotal: | 11165.7000 |
| longTermDebt: | 6281.0000 |
| shortTermDebt: | 0.0000 |
| minorityInterests: | -9.5000 |
| commonStock: | 0.1000 |
| preferredStock: | 0.0000 |
| sales: | 10173.4000 |
| depreciation: | 518.4000 |
| netIncome: | 3046.9000 |
| incomeInterest: | -157.3000 |
| investments: | 2231.1000 |
| incomeTaxes: | 632.8000 |
| costGoodsSold: | 2278.3000 |
| grossProfit: | 7895.1000 |
| minorityInterestsProfit: | -85.3000 |
| cashFlow: | 1384.3000 |
| cashFlowInvesting: | 1576.6000 |
| cashFlowFinancing: | -1747.3000 |
| cashFlowTotal: | 1213.6000 |
| accountingStandard: | US GAAP |
| equityRatio: | 54.5261 |
| debtEquityRatio: | 0.4691 |
| liquidityI: | 1.0448 |
| liquidityII: | 1.5657 |
| netMargin: | 29.9497 |
| grossMargin: | 77.6053 |
| cashFlowMargin: | 13.6071 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 26.8277 |
| preTaxROA: | 14.6281 |
| roe: | 22.7578 |
| roa: | 12.4089 |
| netIncomeGrowth: | 95.8036 |
| revenuesGrowth: | -7.3604 |
| taxExpenseRate: | 17.6179 |
| equityTurnover: | 0.7599 |
| epsBasic: | 20.9600 |
| epsDiluted: | 20.8700 |
| epsBasicGrowth: | 100.7663 |
| shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 3591.8000 |
| priceEarningsRatioCompany: | 13.2118 |
| priceCashFlowRatio: | 28.9034 |
| bookValuePerShare: | 92.6625 |
| marketCap: | 40010965090.3200 |
| earningsYield: | 7.5690 |
| pegRatio: | 0.1311 |
| cashFlowPerShare: | 9.5809 |
| netAssetsPerShare: | 92.5967 |
| priceBookValueRatio: | 2.9885 |
| priceEarningsRatio: | 13.1317 |
| netEarningsPerShare: | 21.0879 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 26844.8000 |
| cash: | 1049.9000 |
| currentAssets: | 6859.3000 |
| fixedAssets: | 19985.5000 |
| liabilities: | 3434.3000 |
| totalLiabilitiesEquity: | 26844.8000 |
| totalShareholdersEquity: | 14799.4000 |
| property: | 3309.7000 |
| intangibleAssets: | 8363.0000 |
| longTermInvestments: | 0.0000 |
| inventories: | 2527.4000 |
| accountsReceivable: | 1664.1000 |
| accountsPayable: | 403.3000 |
| liabilitiesTotal: | 12045.4000 |
| longTermDebt: | 6788.2000 |
| shortTermDebt: | 150.0000 |
| minorityInterests: | 0.0000 |
| commonStock: | 0.1000 |
| preferredStock: | 0.0000 |
| sales: | 9835.6000 |
| depreciation: | 494.8000 |
| netIncome: | 1161.1000 |
| incomeInterest: | -29.6000 |
| investments: | 2462.0000 |
| incomeTaxes: | 135.3000 |
| costGoodsSold: | 2533.4000 |
| grossProfit: | 7302.2000 |
| minorityInterestsProfit: | 0.4000 |
| cashFlow: | 1547.2000 |
| cashFlowInvesting: | -4101.0000 |
| cashFlowFinancing: | 149.3000 |
| cashFlowTotal: | -2404.5000 |
| accountingStandard: | US GAAP |
| equityRatio: | 55.1295 |
| debtEquityRatio: | 0.4688 |
| liquidityI: | 0.3057 |
| liquidityII: | 0.7903 |
| netMargin: | 11.8051 |
| grossMargin: | 74.2425 |
| cashFlowMargin: | 15.7306 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 8.7625 |
| preTaxROA: | 4.8307 |
| roe: | 7.8456 |
| roa: | 4.3252 |
| netIncomeGrowth: | -61.8924 |
| revenuesGrowth: | -3.3204 |
| taxExpenseRate: | 10.4334 |
| equityTurnover: | 0.6646 |
| epsBasic: | 8.0200 |
| epsDiluted: | 7.9700 |
| epsBasicGrowth: | -61.7366 |
| shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 1296.8000 |
| priceEarningsRatioCompany: | 32.2656 |
| priceCashFlowRatio: | 24.3117 |
| bookValuePerShare: | 101.8115 |
| marketCap: | 37615013698.4600 |
| earningsYield: | 3.0993 |
| pegRatio: | -0.5226 |
| cashFlowPerShare: | 10.6439 |
| netAssetsPerShare: | 101.8115 |
| priceBookValueRatio: | 2.5417 |
| priceEarningsRatio: | 32.3960 |
| netEarningsPerShare: | 7.9877 |
| currency: | USD |
| year: | 2024 |
| priceEarningsRatioCompany: | 20.0287 |
| priceCashFlowRatio: | 15.0913 |
| bookValuePerShare: | 101.8115 |
| marketCap: | 23406897584.2000 |
| earningsYield: | 4.9928 |
| pegRatio: | -0.3244 |
| cashFlowPerShare: | 10.6439 |
| netAssetsPerShare: | 101.8115 |
| priceBookValueRatio: | 1.5777 |
| priceEarningsRatio: | 20.1096 |
| netEarningsPerShare: | 7.9877 |
| currency: | USD |
